Successful closure of traumatic macular holes.

Successful closure of traumatic macular holes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Successful closure of traumatic macular holes. Abstract Text:

PURPOSE: To establish the efficacy of vitreoretinal surgery without the use of transforming growth factor-beta or autologous platelet concentrate in the repair of traumatic macular holes. METHODS: This retrospective review consisted of 16 eyes from 16 consecutive patients treated by five vitreoretinal surgeons at a single institution between 1993 and 1997. Intervention included pars plana vitrectomy with creation of posterior vitreous detachment, placement of 14% to 16% C3F8 gas, and postoperative face-down positioning. Ten eyes received intraoperative autologous plasmin to facilitate formation of posterior vitreous detachment. Main outcome measures were anatomic closure rate and visual outcome. RESULTS: Anatomic closure of the macular holes was achieved in 15 (94%) of 16 eyes, with an average follow-up of 7 months. Six (38%) eyes achieved visual acuity of 20/40 or better. Visual acuity improved by 2 or more lines in 11 (69%) of 16 eyes. The average preoperative logMAR-converted visual acuity of 20/175 improved to 20/60 postoperatively. CONCLUSION: Traumatic macular holes can be closed successfully with substantial visual recovery without the use of transforming growth factor-beta or platelet concentrate.

Successful closure of traumatic macular holes. Publishing Authors By Initials

For similar eye diseases: vitreous detachment research abstracts see: eye diseases: vitreous detachment research

PUBMED ID PMID:

MEDLINE DATE:

Successful closure of traumatic macular holes. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Retina (Philadelphia, Pa.)

VOLUME: 19

Page Numbers: 405-9

Journal Abbreviation: Retina (Philadelphia, Pa.)

ISSN: 0275-004X

DAY: 30

MONTH: 05

YEAR: 1999

Successful closure of traumatic macular holes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8309919

Successful closure of traumatic macular holes. Keywords Mesh Terms:

KEYWORDS: Vitreous Detachment

MESH TERMS: surgery

Chemical & Substance for Abstract: Successful closure of traumatic macular holes. Information

Substance Name: Plasmin

Registry Number: EC 3.4.21.7

Grant and Affiliation Information for Successful closure of traumatic macular holes.

AFFILIATION: McGill University, Montreal, Quebec, Canada.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Retina

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Successful closure of traumatic macular holes Related Publications

• Free energy of sickle hemoglobin polymerization: a scaled-particle treatment for use with dextran as a crowding agent.
• HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.
• HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
• HLA class I defects in malignant lesions: what have we learned?
• Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
• Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
• Immune selective pressure and HLA class I antigen defects in malignant lesions.
• Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
• NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance.
• Polymerization and sickle cell disease: a molecular view.
• Soluble HLA-G: Are they clinically relevant?
• Structural polymorphism of human DR antigens.
• Successful closure of traumatic macular holes.
• Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands.
• Universal metastability of sickle hemoglobin polymerization.
• [Not Available.]